financetom
Business
financetom
/
Business
/
Amundi's Q3 net inflows profit from ETF demand, Asian operations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amundi's Q3 net inflows profit from ETF demand, Asian operations
Nov 3, 2024 2:40 PM

PARIS (Reuters) - Amundi, Europe's biggest fund manager, posted in-line quarterly inflows on Wednesday, driven by sustained demand for risk-averse products and its Asian operations.

Net inflows in the third quarter were 2.9 billion euros, bringing total assets under management (AUM) to 2.19 trillion euros at end of September, up 11.1% from a year earlier.

The relatively low amount of net inflows in the third quarter compared with previous quarters stemmed from the loss of a mandate of a large European insurance client, Amundi said.

Analysts had expected net inflows of 2.3 billion euros on average, a consensus compiled by Amundi showed.

Demand for safe investments such as medium and long-term assets through exchange-traded funds and exchange-traded commodities (ETFs and ETCs) brought 7.8 billion euros of net inflows, offsetting an outflow of 7.1 billion euros in active management, driven by equity and multi-asset products.

"On passive management, the market momentum ... is particularly positive for Amundi in the third quarter and for the year as a whole," Chief Executive Valerie Baudson said in a call with reporters.

Amundi's Asian operations, notably its joint venture in India, and third-party distributors also contributed to net inflows.  

The last quarter was marked by the announcement of the planned acquisition of AXA's asset management arm by BNP Paribas. Amundi was among the rival bidders, people with knowledge with the matter have told Reuters. 

News of the tie-up has fueled prospects for more deals in the sector. Most recently, Germany's biggest insurer, Allianz, has been weighing options for its Allianz Global Investors unit, sources close to the matter told Reuters last week. 

"I won't be commenting on market rumors and the Allianz issue," Baudson said when asked if such a deal would draw Amundi's interest.

Amundi remains open to acquisitions, provided the would-be targets meet strict return-on-investment criteria, she added. 

Amundi, which is controlled by French bank Credit Agricole, posted growth of 16.1% in third-quarter adjusted net income to 337 million euros, in line with the 333 million-euro estimate expected by analysts. Revenue over the period rose 10.5% to 862 million euros.

($1 = 0.9261 euro)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nortech Systems Q3 net loss narrows due to restructuring efforts 
Nortech Systems Q3 net loss narrows due to restructuring efforts 
Nov 13, 2025
Overview * Nortech Q3 2025 net sales decline 2.9% yr/yr to $30.5 mln * Net loss narrows to $146,000 in Q3 2025 from $739,000 in Q3 2024 * Adjusted EBITDA rises to $1.3 mln in Q3 2025 from $0.1 mln in Q3 2024 Outlook * Company highlights AS9100:D certification at Monterrey facility enhancing aerospace offerings * Nortech ( NSYS )...
BioNTech says collaboration with Pfizer remains unchanged
BioNTech says collaboration with Pfizer remains unchanged
Nov 13, 2025
FRANKFURT, Nov 13 (Reuters) - BioNTech said on Thursday that its collaboration with Pfizer ( PFE ) has not changed, when asked to comment on a report that Pfizer ( PFE ) is looking to sell its stake in the German biotech firm. We continue to have a close and strong collaboration, a spokesperson said in a statement, adding that...
DiamondRock Hospitality to Transfer Listing to Nasdaq From NYSE
DiamondRock Hospitality to Transfer Listing to Nasdaq From NYSE
Nov 13, 2025
08:14 AM EST, 11/13/2025 (MT Newswires) -- DiamondRock Hospitality ( DRH ) said Thursday it will voluntarily transfer its class A common shares listing to Nasdaq from the New York Stock Exchange. The company said it anticipates its common shares to start trading on the Nasdaq Global Select Market on Dec. 1, under the current DRH ticker. ...
Genetic medicines firm MeiraGTx misses Q3 revenue expectations, net loss widens
Genetic medicines firm MeiraGTx misses Q3 revenue expectations, net loss widens
Nov 13, 2025
Overview * MeiraGTx ( MGTX ) Q3 revenue misses analyst expectations, declining significantly from last year * Company enters strategic collaboration with Eli Lilly, including $75 mln upfront payment * Net loss widens to $50.5 mln in Q3, driven by increased R&D expenses Outlook * Company anticipates Phase 2 data for AAV-hAQP1 in early 2027 * MeiraGTx ( MGTX )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved